The androgen receptor—lncRNA SAT1- AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells

GND
1241282765
Affiliation
Institute of Human Genetics, Jena University Hospital, Jena, Germany
Mirzakhani, Kimia;
GND
1241282161
Affiliation
Institute of Human Genetics, Jena University Hospital, Jena, Germany
Kallenbach, Julia;
GND
1241283192
Affiliation
Leibniz Institute on Aging, Jena, Germany
Rasa, Seyed Mohammad Mahdi;
GND
1242100113
Affiliation
Institute of Human Genetics, Jena University Hospital, Jena, Germany
Ribaudo, Federico;
GND
122845082X
Affiliation
Institute of Human Genetics, Jena University Hospital, Jena, Germany
Ungelenk, Martin;
GND
1231240458
Affiliation
Institute of Human Genetics, Jena University Hospital, Jena, Germany
Ehsani, Marzieh;
Affiliation
SCW Medicath LTD, Baolong industrial Town, Shenzhen, China
Gong, Wenrong;
GND
1076884180
Affiliation
Section of Pathology, Institute of Forensic Medicine, Jena University Hospital, Jena, Germany
Gassler, Nikolaus;
Affiliation
Institute of Human Genetics, Jena University Hospital, Jena, Germany
Leeder, Mirjam;
GND
115682899
Affiliation
Department of Adult and Pediatric Urology, Jena University Hospital, Jena, Germany
Grimm, Marc-Oliver;
GND
1241284555
Affiliation
Leibniz Institute on Aging, Jena, Germany
Neri, Francesco;
GND
112808337X
ORCID
0000-0003-1085-9161
Affiliation
Institute of Human Genetics, Jena University Hospital, Jena, Germany
Baniahmad, Aria

The bipolar androgen therapy (BAT) to treat prostate cancer (PCa) includes cycles of supraphysiological androgen levels (SAL) under androgen-deprivation therapy (ADT). We showed previously that SAL induces cellular senescence in androgen-sensitive PCa cells and in ex vivo-treated patient PCa tumor samples. Here, we analyzed the underlying molecular pathway and reveal that SAL induces cellular senescence in both, castration-sensitive (CSPC) LNCaP and castration-resistant PCa (CRPC) C4-2 cells through the cell cycle inhibitor p15 INK4b and increased phosphorylation of AKT. Treatment with the AKT inhibitor (AKTi) potently inhibited SAL-induced expression of p15 INK4b and cellular senescence in both cell lines. Proximity-ligation assays (PLA) combined with high-resolution laser-scanning microscopy indicate that SAL promotes interaction of endogenous androgen receptor (AR) with AKT in the cytoplasm as well as in the nucleus detectable after three days. Transcriptome sequencing (RNA-seq) comparing the SAL-induced transcriptomes of LNCaP with C4-2 cells as well as with AKTi-treated cell transcriptomes revealed landscapes for cell senescence. Interestingly, one of the identified genes is the lncRNA SAT1 . SAL treatment of native patient tumor samples ex vivo upregulates lncRNA SAT1 . In PCa tumor tissues, lncRNA SAT1 is downregulated compared with nontumor tissues of the same patients. Knockdown indicates that the lncRNA SAT1 is crucial for SAL-induced cancer-cell senescence as an upstream factor for pAKT and for p15 INK4b . Further, knockdown of lncRNA SAT1 enhances cell proliferation by SAL, suggesting that lncRNA SAT1 serves as a tumor suppressor at SAL. Interestingly, immunoprecipitation of AR detected lncRNA SAT1 as an AR-interacting partner that regulates AR target-gene expression. Similarly, RNA-ChIP experiments revealed the interaction of AR with lncRNA SAT1 on chromatin. Thus, we identified a novel AR-lncRNA SAT1 -AKT-p15 INK4b signaling axis to mediate SAL-induced cellular senescence.

Cite

Citation style:
Could not load citation form.

Rights

License Holder: © The Author(s) 2021

Use and reproduction: